Skip to main content
OpenTrials
Completed

NCT Number: NCT00441493

Fluvastatin Versus Hepatitis C Virus

This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis C Blood-Borne Infections Communicable Diseases Digestive System Diseases Flaviviridae Infections Hepatitis Hepatitis, Viral, Human Infections Liver Diseases RNA Virus Infections Virus Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

VA Medical Center

Oklahoma City, Oklahoma, 73104, United States

About this study

Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HCV RNA positive

Exclusion criteria

  • Testing positive for alcohol or marijuana

Treatment and study plan

Fluvastatin

Drug

Primary outcomes

  1. Viral Load Reduction, Liver test changes

Sponsors and collaborators

Lead sponsor

Bader, Ted, M.D.

Indiv

Collaborators

  • US Department of Veterans Affairs

Registry information

Official study title

A Dose Finding Study of Fluvastatin for in Vivo Demonstration of Inhibiting Hepatitis C Replication in Patients Infected With Chronic Hepatitis C With Special Attention to the African-American Population.

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Mar 1, 2007
Registry last updated
Jul 27, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.